The Future Is Now: Model-Based Clinical Trial Design for Alzheimer’s Disease

Failures in trials for Alzheimer’s disease (AD) may be attributable to inadequate dosing, population selection, drug inefficacy, or insufficient design optimization. The Coalition Against Major Diseases (CAMD) was formed in 2008 to develop drug development tools (DDT) to expedite drug development fo...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacol Ther
主要な著者: Romero, K, Ito, K, Rogers, JA, Polhamus, D, Qiu, R, Stephenson, D, Mohs, R, Lalonde, R, Sinha, V, Wang, Y, Brown, D, Isaac, M, Vamvakas, S, Hemmings, R, Pani, L, Bain, LJ, Corrigan, B
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463482/
https://ncbi.nlm.nih.gov/pubmed/25669145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.16
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料